News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
159 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21900)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (15)
2 (105)
3 (183)
4 (159)
5 (95)
6 (86)
9 (195)
10 (158)
11 (164)
12 (134)
13 (88)
16 (146)
17 (114)
18 (152)
19 (152)
20 (84)
23 (128)
24 (33)
25 (4)
26 (8)
27 (6)
29 (16)
30 (34)
31 (32)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
29
30
31
Policy
Trump Administration a Mixed Bag for Biopharma
President-elect Donald Trump and his incoming administration are unlikely to attempt a wholesale restructuring of U.S. healthcare and could promote M&A activity, but controversial picks like Robert F. Kennedy could impact vaccine sales, experts say.
December 4, 2024
·
3 min read
·
Annalee Armstrong
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
One year after a potential $1.7 billion deal with Hansoh Pharma, GSK goes back to China to forge another alliance with DualityBio for another deal that could be worth up to $1 billion as it continues to build up its ADC portfolio.
December 4, 2024
·
1 min read
·
Kate Goodwin
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
The Danish startup, whose lead candidate has parallels to Amgen’s MariTide, launches on the heels of Amgen’s Phase II data release for the drug last week.
December 4, 2024
·
2 min read
·
Heather McKenzie
Press Releases
Oncoinvent Announces Agreement with ARTBIO to Collaborate on Radiopharma Laboratory Facilities
December 4, 2024
·
2 min read
Press Releases
UK MHRA Grants Innovation Passport Designation to ILiAD Biotechnologies BPZE1 Next Generation Intranasal Pertussis Vaccine
December 4, 2024
·
5 min read
Press Releases
American Aires Engages ICP Securities Inc. (ICP) for Automated Market Making Services
December 4, 2024
·
6 min read
Press Releases
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
December 4, 2024
·
5 min read
Press Releases
Groundbreaking Research from UPMC Highlights Opioids’ Suppressive Impact on Immune Checkpoint Inhibitors and the Potential of Axelopran, an Opioid Antagonist to Reverse It
December 4, 2024
·
1 min read
Press Releases
Ossium Health to Participate at the 66th American Society of Hematology Annual Meeting and Exposition
December 4, 2024
·
1 min read
Press Releases
Downstream Processing Market Size to Reach USD 101.43 Billion By 2033
December 4, 2024
·
1 min read
Previous
15 of 16
Next
